
Belén Garijo, Merck KGaA CEO (Hollie Adams/Bloomberg via Getty Images)
No news is good news? Merck KGaA quiet on potential SpringWorks takeover
Ahead of Merck KGaA’s earnings announcement Thursday, investors were mostly looking forward to any comments about its potential buyout of SpringWorks Therapeutics. But the German …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.